88179774 - LTS SMART

Information

• Trademark
• 88179774

• Source

• Serial Number

  88179774

• Registration Number

  5993702

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 20 - Furniture, mirrors, picture frames
  • 21 - Household or kitchen utensils and containers
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 02, 2018
  6 years ago

• Registration Date

  February 25, 2020
  4 years ago

• Transaction Date

  February 25, 2020
  4 years ago

• Status Date

  February 25, 2020
  4 years ago

• Published for Opposition Date

  December 10, 2019
  5 years ago

• Location Date

  February 25, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EULIN, INGRID C

• Attorney Docket Number

  7174-1807429

  Attorney Name

  Kirk M. Miles, Registration No. 37,891

  Law Office Assigned Location Code

  M20

• Owners

  • LTS Lohmann Therapie-Systeme AG

Case File Statements

• D10000: "SMART"
• GS0011: Chemicals used in industry; chemicals used in science; injection preparations for needle-free injection, for injection by means of needles, or injection by cannula systems, namely, chemicals for use in agriculture, horticulture, and in forestry, except fungicides, herbicides, insecticides and parasiticides, the aforesaid products and injection preparations being for livestock farming or animal breeding, including aquaculture
• GS0051: Pharmaceutical and veterinary preparations, namely, injectable pharmaceutical and veterinary preparations for the prevention and treatment of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists by intracutaneous, intradermal, subcutaneous, intramuscular, intravenous and intra-articular injection, the aforesaid injection preparations being for needle-free injection or for injection by means of needle or cannula systems; injectable pharmaceutical and veterinary preparation therapeutic or prophylactic ingredients or diagnostic preparations, namely, pharmaceutical and therapeutic preparations for use with pets, laboratory animals, wild animals, zoo animals and livestock, including aquaculture, for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; preparations for destroying vermin; fungicides; herbicides; pharmaceuticals for use in the gastrointestinal tract, subcutaneous use and for oral use for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; medicines for administration in the form of plasters and wafers containing active ingredients, namely, medicines for the treatment of gastrointestinal diseases; medical plasters containing active ingredients for transdermal administration of active ingredients, medical plasters containing active ingredients for topical processing of active ingredients, and for manufacturing active ingredient-free laminates
• GS0101: Surgical, medical, dental and veterinary instruments and apparatus, namely, instruments and apparatus for injecting substances, in particular infusion and injection device for administering drugs, needle-free, via needles, by cannulae, or through an injection systems comprised primarily of a needle-free injection device, ampoules, storage bottles and accessories for injection devices; dropper bottle for administering medication, sold empty; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies for use in dermal, transdermal, mucosal and transmucosal sampling of bodily fluids; medical devices and instruments for administering pharmaceuticals and biotechnological molecules using needle-like microstructures, plaster needles for medical purposes for use on the skin; injection device for pharmaceuticals, namely, medical injection device for administering drugs; parts for the aforesaid goods, in particular microneedles and/or microneedle assemblies for use in administering pharmaceuticals and biotechnological molecules
• GS0201: Nonmetal and non-paper containers for storage or transport of injection devices consisting of needle-free injection systems or systems for injection using needles or cannulae, medical products
• GS0211: Ampoules for medication sold empty
• GS0421: Scientific and technological services and research, namely, development of pharmaceuticals veterinary preparations and medicines, up to the production stage; conducting of analytical testing of pharmaceuticals and veterinary preparations; new product design with respect to health care products in the nature of pharmaceutical and veterinary preparations; industrial analysis and research, namely, testing, analysis and evaluation of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae and the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules of others to assure compliance with industry standards; design and development of computer hardware and software
• GS0441: Medical services; veterinary services; pharmaceutical consultation; hygienic care for human beings; beauty care for human beings; animal healthcare services, namely, veterinary services; animal beautician services, namely, pet grooming services; agriculture services, namely, compost spreading; horticultural services; forestry, namely, insecticide spraying for forestry; all of the aforesaid in the field of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae; medical consultations for patients and qualified personnel, in particular doctors, in relation to medicine delivery systems and instruments, in particular comprising microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; preparation and administration of medicines, including by means of plasters for use on the skin, namely, preparation of prescriptions by pharmacists
• PM0001: LOHMANN THERAPIE-SYSTEME SMART

Case File Event Statements

• 2/25/2020 - 4 years ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/10/2019 - 5 years ago

  26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/10/2019 - 5 years ago

  25 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/20/2019 - 5 years ago

  24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/4/2019 - 5 years ago

  23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/4/2019 - 5 years ago

  22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 11/4/2019 - 5 years ago

  21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 11/4/2019 - 5 years ago

  20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 11/4/2019 - 5 years ago

  19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/31/2019 - 5 years ago

  18 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 10/31/2019 - 5 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/29/2019 - 5 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/29/2019 - 5 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/28/2019 - 5 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 10/22/2019 - 5 years ago

  13 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 8/12/2019 - 5 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 8/12/2019 - 5 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 8/12/2019 - 5 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 8/10/2019 - 5 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/9/2019 - 5 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/9/2019 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/11/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/11/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/11/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/8/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/18/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 11/6/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP